Crossmark

Rising Prevalence of Obesity and Primary Hyperaldosteronism: Co-incidence or Connected Circumstances Leading to Hypertension? A Narrative Review

Published Online: 2024-10-16

Published Print: 2025-03

Authors

Bansal, Shweta https://orcid.org/0000-0002-3306-2799
Puzantian, Houry

Townsend, Raymond R.
Funding

Funding for this research was provided by:

National Center for Advancing Translational Sciences (UM1 TR004538)
License Information

Text and Data Mining valid from 2024-10-16

Version of Record valid from 2024-10-16
More Information

Article History

Received: 3 June 2024

Accepted: 24 September 2024

First Online: 16 October 2024

Declarations:

:

: SB: Royalty from UpToDate; Advisory board member to Novartis, Calliditas, Vera, Travere and Daxor; Research funding from Novonordisk, AstraZeneca and Bayer; Speaker bureau: Home dialysis university.HP: Intra-mural Institutional research grant.RRT: Consultant to Medtronic, Regeneron, AstraZeneca, Bard, Orchestra Backbeat; DSMB member AXIO, NOVARTIS, NIH; Royalty from UpToDate.

Document is current